Ryad Bennaï
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ryad Bennaï has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Fodil Azzaz
Department of Biology, Faculty of Medicine, University of Aix-Marseille, INSERM UA16, 13015 Marseille, France
1 shared publication - Henri Chahinian
Department of Biology, Faculty of Medicine, University of Aix-Marseille, INSERM UA16, 13015 Marseille, France
1 shared publication - Jacques Fantini
Department of Biology, Faculty of Medicine, University of Aix-Marseille, INSERM UA16, 13015 Marseille, France
1 shared publication - Nouara Yahi
Department of Biology, Faculty of Medicine, University of Aix-Marseille, INSERM UA16, 13015 Marseille, France
1 shared publication
Latest Publications
- Open Access
- 23 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 10194
Cholesterol-Dependent Serotonin Insertion Controlled by Gangliosides in Model Lipid Membranes
Serotonin is distinct among synaptic neurotransmitters because it is amphipathic and released from synaptic vesicles at concentrations superior to its water solubility limit (270 mM in synaptic vesicles for a solubility limit of 110 mM). Hence, serotonin is mostly aggregated in the synaptic cleft, due to extensive aromatic stacking. This important characteristic has received scant attention, as most representations of the serotonergic synapse take as warranted that serotonin molecules are present as monomers after synaptic vesicle exocytosis. Using a combination of in silico and physicochemical approaches and a new experimental device mimicking synaptic conditions, we show that serotonin aggregates are efficiently dissolved by gangliosides (especially GM1) present in postsynaptic membranes. This initial interaction, driven by electrostatic forces, attracts serotonin from insoluble aggregates and resolves micelles into monomers. Serotonin also interacts with cholesterol via a set of CH-π and van der Waals interactions. Thus, gangliosides and cholesterol act together as a functional serotonin-collecting funnel on brain cell membranes. Based on this unique mode of interaction with postsynaptic membranes, we propose a new model of serotonergic transmission that takes into account the post-exocytosis solubilizing effect of gangliosides and cholesterol on serotonin aggregates.
- 23 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 10194
Open AccessCholesterol-Dependent Serotonin Insertion Controlled by Gangliosides in Model Lipid Membranes
Serotonin is distinct among synaptic neurotransmitters because it is amphipathic and released from synaptic vesicles at concentrations superior to its water solubility limit (270 mM in synaptic vesicles for a solubility limit of 110 mM). Hence, serotonin is mostly aggregated in the synaptic cleft, due to extensive aromatic stacking. This important characteristic has received scant attention, as most representations of the serotonergic synapse take as warranted that serotonin molecules are present as monomers after synaptic vesicle exocytosis. Using a combination of in silico and physicochemical approaches and a new experimental device mimicking synaptic conditions, we show that serotonin aggregates are efficiently dissolved by gangliosides (especially GM1) present in postsynaptic membranes. This initial interaction, driven by electrostatic forces, attracts serotonin from insoluble aggregates and resolves micelles into monomers. Serotonin also interacts with cholesterol via a set of CH-π and van der Waals interactions. Thus, gangliosides and cholesterol act together as a functional serotonin-collecting funnel on brain cell membranes. Based on this unique mode of interaction with postsynaptic membranes, we propose a new model of serotonergic transmission that takes into account the post-exocytosis solubilizing effect of gangliosides and cholesterol on serotonin aggregates.